Posted in | Preclinical Imaging

In Vivo Tumor Progression Studies: The Relative Strengths of Available Imaging Modalities and Reporter Constructs

From Jun 8 2017

Combining preclinical in vivo imaging modalities offers the opportunity to synergize the strengths of each in one experiment. For example, optical imaging offers the ability to non-invasively and longitudinally track molecular and cellular events, frequently using bioluminescence or fluorescence genetic reporters. But this can be further enhanced when combined with dedicated high performance micro-CT, to provide high resolution anatomical data.

Seminar overview

In this webinar, Dr. Kah-Wye Peng, Chief Operating Officer at Imanis Life Sciences, will outline the range of products and genetic reporters systems and reagents offered by the company for use in optical and nuclear imaging. Imanis provide reporter gene cell lines, lentiviruses, oncolytic viruses, antibodies, lentiviral plasmids and custom products to support non-invasive reporter gene imaging and oncolytic virology research.

Dr. Peng will be joined on the webinar by co-presenter Dr. Andrew Van Praagh, Field Applications Scientist, from Bruker BioSpin, who will describe some of the research facilitated by bringing together the products and reagents offered by Imanis with the state-of-the-art multimodal imaging technology delivered by Bruker.

Presenters

New presenters june 8

Dr. Kah-Wye Peng (biography)
Chief Operating Officer, Imanis Life Sciences

Dr. Andrew Van Praagh (biography)
Field Applications Scientist, Bruker BioSpin

What you will discover?

During this webinar, Peng will outline the various products her company have been making available to researchers since founding in 2012. This includes facilitating imaging with fluorescence, bioluminescence and radioisotopes. She will highlight the benefits of multimodal imaging, including early detection, high sensitivity and accelerated drug development. The webinar will also illustrate how the products offered by Imanis Life Sciences perfectly complement Bruker’s technology.

Dr. Van Praagh will demonstrate some specific examples of preclinical research drawing together the technology from both companies. He will also highlight how the Bruker In Vivo Xtreme II imaging system combines four imaging modalities – luminescence, fluorescence, radioisotope imaging and X-ray – in one to deliver an unparalleled level of sensitivity, speed and versatility in preclinical imaging. Further, the relative strengths for Optical, microCT, and MRI imaging in tumor progression studies will be reviewed.

Key topics

  • Applications of the technology
  • Reporters for multimodal imaging
  • Longitudinal tumor imaging
  • Bruker’s In Vivo Xtreme II Optical/X-ray system

Who should attend?

This webinar will interest oncologists and cancer researchers as well as people working in imaging and the virus gene therapy market. It is also highly relevant for people working in drug development, particularly in the areas of oncology and infectious diseases.

Other Webinars from Bruker BioSpin - NMR, EPR and Imaging

Dynamic Nuclear Polarization in the study of pharmaceuticals

Dynamic Nuclear Polarization in the study of pharmaceuticals
Potency Determination by qNMR

Potency Determination by qNMR
High speed spectroscopy – New AVANCE NEO

High speed spectroscopy – New AVANCE NEO
Is it really pure honey? Detecting adulterations, frauds and quality issues by NMR-based Honey-Profiling

Is it really pure honey? Detecting adulterations, frauds and quality issues by NMR-based Honey-Profiling
Solid State NMR Made Easy

Solid State NMR Made Easy
Studying Cancer biology and Therapeutic Targets Using PET Technology: Opening an Extraordinary Option

Studying Cancer biology and Therapeutic Targets Using PET Technology: Opening an Extraordinary Option
Automatizing the qualitative and quantitative analysis of complex drugs using NMR

Automatizing the qualitative and quantitative analysis of complex drugs using NMR
Imaging of Infection and Tumors using labelled Siderophores

Imaging of Infection and Tumors using labelled Siderophores
Metabolic Imaging in Neurodegenerative Disease using CEST MRI

Metabolic Imaging in Neurodegenerative Disease using CEST MRI
In vivo Magnetic Resonance Imaging

In vivo Magnetic Resonance Imaging
NMR-based fragment screening for drug discovery

NMR-based fragment screening for drug discovery
Pharmaceutical Applications of Electron Paramagnetic Resonance (EPR) Spectroscopy

Pharmaceutical Applications of Electron Paramagnetic Resonance (EPR) Spectroscopy
Improving Mechanistic Understanding of Fast Reactions Using Rapid, Reproducible In Situ Analysis by Stop-Flow NMR and IR

Improving Mechanistic Understanding of Fast Reactions Using Rapid, Reproducible In Situ Analysis by Stop-Flow NMR and IR
A Universal MicroCT Analysis Pipeline for Bone Preclinical Disease Models

A Universal MicroCT Analysis Pipeline for Bone Preclinical Disease Models
EPR as a Teaching Tool in the Laboratory

EPR as a Teaching Tool in the Laboratory
How microCT Can Provide Insight into Dynamic Disease Processes

How microCT Can Provide Insight into Dynamic Disease Processes
Solid Form Quantification – A New Benchtop Solution

Solid Form Quantification – A New Benchtop Solution
Webinar Overview: EPR as a Teaching Tool in the Laboratory

Webinar Overview: EPR as a Teaching Tool in the Laboratory
Intelligent Use of NMR for Synthetic Organic Chemistry

Intelligent Use of NMR for Synthetic Organic Chemistry
Early Disease Detection Performing NMR

Early Disease Detection Performing NMR
Using Micro-CT Imaging for the Phenotyping and Analysis of Bone Architecture

Using Micro-CT Imaging for the Phenotyping and Analysis of Bone Architecture
Using High Fields to Combat Ischemic Stroke with Cell Therapy

Using High Fields to Combat Ischemic Stroke with Cell Therapy
Endodontic Applications of Microcomputed Tomography for Studying Root Canals

Endodontic Applications of Microcomputed Tomography for Studying Root Canals
Studying Cardiovascular Pathology with MRI

Studying Cardiovascular Pathology with MRI
Improved Open-Access NMR for the Synthetic and Analytical Chemistry Laboratories

Improved Open-Access NMR for the Synthetic and Analytical Chemistry Laboratories
DTI Connectomics in Mouse Models of Neurological Disorders

DTI Connectomics in Mouse Models of Neurological Disorders
Monitoring Cancer Treatments with Immuno-PET

Monitoring Cancer Treatments with Immuno-PET
Early Detection of Metabolic Remodeling in Pressure Overload Left Ventricle Hypertrophy Using Dynamic PET Imaging

Early Detection of Metabolic Remodeling in Pressure Overload Left Ventricle Hypertrophy Using Dynamic PET Imaging
MicroCT Applications in Lung Research and Immunology

MicroCT Applications in Lung Research and Immunology
Micro-CT in 3D Data Integration and (Clinical) Workflows for Digital Orthodontics

Micro-CT in 3D Data Integration and (Clinical) Workflows for Digital Orthodontics
Ex Vivo MicroangioCT: Advances in Microvascular Imaging

Ex Vivo MicroangioCT: Advances in Microvascular Imaging
Treatments of COVID-19: Old Drugs, New Tricks

Treatments of COVID-19: Old Drugs, New Tricks
NMR Characterization of Polysaccharide-Based Vaccines

NMR Characterization of Polysaccharide-Based Vaccines
Hyperpolarized Xe MRI of Pulmonary Gas-Exchange in Rodents

Hyperpolarized Xe MRI of Pulmonary Gas-Exchange in Rodents
PET Image Reconstruction Overview - Current and Future Trends

PET Image Reconstruction Overview - Current and Future Trends
Unlocking your clinical understanding of Post-Acute COVID Syndrome (PACS), patient recover, and risk of subsequent disease

Unlocking your clinical understanding of Post-Acute COVID Syndrome (PACS), patient recover, and risk of subsequent disease
New Psychoactive Substances (NPS): automated identification and quantification

New Psychoactive Substances (NPS): automated identification and quantification
Present and future of human metabolomics (for research use only)

Present and future of human metabolomics (for research use only)
NMR based lipoprotein phenotyping can reveal recovery subgroups in SARS-CoV 2 infected patients

NMR based lipoprotein phenotyping can reveal recovery subgroups in SARS-CoV 2 infected patients
How to easily automate chemical mixture analysis

How to easily automate chemical mixture analysis
Evolving your biobank business model

Evolving your biobank business model
Improving rapid narcotics analysis in the detection of illegal drugs

Improving rapid narcotics analysis in the detection of illegal drugs
PET/MR imaging to study liver diseases

PET/MR imaging to study liver diseases

Life Science Webinars by Subject Matter

Watch the
Webinar

More Articles from
Bruker BioSpin - NMR, EPR and Imaging

More Products from
Bruker BioSpin - NMR, EPR and Imaging

See all content from Bruker BioSpin - NMR, EPR and Imaging
Watch the
Webinar

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback